Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Non-Current Assets (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Other Non-Current Assets for 12 consecutive years, with $3.8 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 751.56% year-over-year to $3.8 million; the TTM value through Mar 2026 reached $3.8 million, up 751.56%, while the annual FY2025 figure was $3.8 million, 0.16% changed from the prior year.
  • Other Non-Current Assets hit $3.8 million in Q1 2026 for Wave Life Sciences, roughly flat from $3.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.7 million in Q1 2023 and bottomed at $22000.0 in Q3 2025.
  • Average Other Non-Current Assets over 5 years is $2.2 million, with a median of $3.7 million recorded in 2022.
  • Year-over-year, Other Non-Current Assets surged 2335.9% in 2024 and then crashed 99.41% in 2025.
  • Wave Life Sciences' Other Non-Current Assets stood at $62000.0 in 2022, then surged by 151.61% to $156000.0 in 2023, then soared by 2335.9% to $3.8 million in 2024, then grew by 0.16% to $3.8 million in 2025, then rose by 0.24% to $3.8 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $3.8 million, $3.8 million, and $22000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.